Business context and reporting period
Encore Capital Group, Inc. filed this Form 10-K for the fiscal year ended December 31, 2023. The company buys defaulted consumer receivables at a discount and collects on them, primarily through MCM in the United States and Cabot in Europe and the UK. It also provides European debt-servicing services. LAAP operations remain immaterial to consolidated results.
Financial performance and liquidity
| Metric | FY 2023 | FY 2022 |
|---|---|---|
| Total revenue | $1,222.7 million | $1,398.3 million |
| Operating income | $16.5 million | $462.2 million |
| Net income (loss) | $(206.5) million | $194.6 million |
| Adjusted EBITDA | $333.6 million | $529.6 million |
| Cash from operating activities | $153.0 million | $210.7 million |
| Cash and cash equivalents at year-end | $158.4 million | $143.9 million |
| Borrowings, net of debt discount and issuance costs | $3,318.0 million | $2,898.8 million |
- Revenue declined 12.6%. Debt-purchasing revenue was $1,121.9 million, down 13.4%; servicing revenue fell 12.4% to $83.1 million. Portfolio revenue before changes in recoveries was nearly flat at $1,204.4 million.
- Operating margin fell to about 1.4% from 33.1%; net margin was about negative 16.9%. The net loss included a $238.2 million non-cash Cabot goodwill impairment and $18.7 million intangible-asset impairment. Interest expense rose 31.7% to $201.9 million.
- Adjusted EBITDA, a non-GAAP measure, declined 37.0%. Investors should consider the company’s reconciliation and adjustments when comparing it with GAAP results.
- Gross collections from purchased receivables were $1,862.6 million, down 2.6%. Portfolio purchases increased 34.1% to $1,073.8 million, including $814.6 million in the U.S. and $259.3 million in Europe.
- Investment in receivable portfolios, net, was $3,468.4 million at year-end. Estimated remaining gross collections were $8,065.7 million for portfolios and $126.3 million for real estate-owned assets; these are estimates, not guaranteed cash flows.
- Net cash used in investing was $401.9 million, principally reflecting portfolio purchases. Financing activities provided $268.3 million. Cash included $16.0 million collected for third-party clients; $125.8 million was held by foreign entities, most of it indefinitely reinvested.
- Available capacity under the Global Senior Facility was $363.8 million. Management said liquidity was sufficient for at least the next 12 months and reported material compliance with debt covenants. The company made no share repurchases in 2023 and had $91.9 million of repurchase authorization remaining.
Material changes versus the prior comparable period
- Recoveries were $82.5 million below forecast in 2023, compared with $93.1 million above forecast in 2022. The company also reduced estimated future recoveries by a net $49.1 million, primarily for U.S. portfolios purchased in 2021 and 2022, citing consumer payment patterns normalizing after pandemic-era distortions.
- The fourth-quarter Cabot goodwill test resulted in a $238.2 million impairment. Management cited lower-than-expected European unsecured borrowing and charge-off levels, portfolio pricing it believes has not fully reflected higher funding costs, and capital allocated to higher-return U.S. markets. Cabot goodwill was $457.5 million after impairment; its carrying value equaled fair value immediately after the charge.
- Interest expense increased $48.6 million, mainly due to higher rates and higher average debt. The weighted-average rate on the Global Senior Facility rose to 7.58% from 4.42%.
- U.S. purchases rose as supply increased and pricing improved, while European portfolio supply remained below pre-pandemic levels and pricing competitive, with improvement reported in the fourth quarter. U.S. revenue declined to $792.4 million from $995.5 million; Europe revenue increased to $429.9 million from $402.7 million.
Outlook, risks, contingencies and unusual items
- The filing provides no specific earnings or revenue guidance. Management expects U.S. supply to continue growing, but results depend on portfolio availability, purchase prices, collection performance and consumer behavior. It expects legacy zero-basis portfolio revenue to decline.
- Management’s stated priorities include investment in U.S. and UK portfolio purchasing, developing selected European markets, strengthening the balance sheet and deploying capital for risk-adjusted returns. It may use excess cash for debt reduction or, depending on leverage and other factors, share repurchases.
- Key risks include inaccurate collection forecasts, economic stress and consumer inability to pay, competition for portfolios, concentration among sellers, interest-rate and foreign-exchange exposure, high indebtedness, and extensive consumer-protection, privacy and licensing requirements. Litigation, regulatory action, cybersecurity events and reliance on third-party collectors and law firms could also affect results.
- Outstanding contractual debt principal was $3,355.7 million; estimated interest payments were $736.2 million. Contractual cash obligations totaled $4,574.8 million, including $384.6 million of estimated minimum forward-flow purchase commitments. Variable-rate debt and refinancing needs create additional exposure.
- The company disclosed ongoing state Attorney General investigations related to debt-collection practices and stated that it had no material legal reserves at year-end. It described the 2020 CFPB stipulated judgment, including a $15.0 million penalty, as resolved; related operational requirements continue. Management believes pending matters will not have a material adverse effect, while noting outcomes cannot be assured.
- The financial-statement auditor gave an unqualified opinion and also reported effective internal control over financial reporting. The auditors identified expected future recoveries and goodwill impairment valuation as critical audit matters.
Important facts for investors to verify
- Whether actual collections and forecast revisions for the 2021–2022 U.S. vintages support management’s remaining-recovery estimates.
- Whether Cabot’s outlook, market assumptions and carrying value support the goodwill remaining after the impairment, and whether further impairment indicators emerge.
- Debt maturities, interest-rate exposure, covenant headroom and the availability of the stated revolving-facility capacity as portfolio purchases continue.
- Whether higher U.S. purchasing volumes produce returns consistent with underwriting assumptions, and whether European supply and pricing improve enough to support Cabot’s forecasts.
- Developments in state Attorney General investigations, other litigation and regulatory requirements, including any changes to collection practices or costs.
- Cash availability by entity and jurisdiction, including the amount held for clients and any tax or other effects of repatriating foreign cash.